Article

wsj.comwsj.com on 2019-06-25 17:18

AbbVie and Big Pharma: No Miracle Cures

Investors aren’t pleased with AbbVie’s $63 billion purchase of Allergan, but industry dynamics demand unpopular megadeals.

Related news